Advertisement
Australia markets close in 1 hour 1 minute
  • ALL ORDS

    7,947.50
    +22.30 (+0.28%)
     
  • ASX 200

    7,695.30
    +19.50 (+0.25%)
     
  • AUD/USD

    0.6542
    -0.0018 (-0.27%)
     
  • OIL

    82.52
    -0.20 (-0.24%)
     
  • GOLD

    2,164.90
    +0.60 (+0.03%)
     
  • Bitcoin AUD

    100,520.54
    -3,038.73 (-2.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6013
    -0.0014 (-0.23%)
     
  • AUD/NZD

    1.0772
    -0.0006 (-0.06%)
     
  • NZX 50

    11,806.50
    +78.49 (+0.67%)
     
  • NASDAQ

    17,985.01
    +176.76 (+0.99%)
     
  • FTSE

    7,722.55
    -4.87 (-0.06%)
     
  • Dow Jones

    38,790.43
    +75.66 (+0.20%)
     
  • DAX

    17,932.68
    -3.97 (-0.02%)
     
  • Hang Seng

    16,737.12
    +0.02 (+0.00%)
     
  • NIKKEI 225

    39,591.37
    -149.07 (-0.38%)
     

Tauriga Sciences Inc. to Further Expand its Product Offerings With Dark Chocolate [20mg] CBD Infused Round Medallions

December 4 PR

Artist’s Rendition of CBD Infused Dark Chocolate Medallion
Artist’s Rendition of CBD Infused Dark Chocolate Medallion
Artist’s Rendition of CBD Infused Dark Chocolate Medallion

NEW YORK, NY, Dec. 04, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the further expansion of its product offerings – with the development of dark chocolate [20mg] CBD Infused Round Medallions (“Medallions”). Each dark chocolate medallion will be infused with 20mg CBD Isolate and will be sold exclusively on the Company’s E-Commerce website: www.taurigum.com. Additionally these dark chocolate medallions will be: lab tested, kosher certified, cholesterol free, NON-GMO, THC Free, and Only 49 Calories per medallion.

ADVERTISEMENT

Manufacturer’s Suggested Retail Price (“MSRP”): $4.99 Each or $12.99 for Pack of 3 Medallions

In other news, the Company is firmly on track to report record quarterly sales – for its current operating quarter (3rd Fiscal Quarter 2021 / Period: October 1, 2020 thru December 31, 2020). Lastly, the Company is pleased with the initial sales of its Limited Edition Hanukkah Special Gift Pack (“Hanukkah Special”) and is expecting a sharp increase over the next 15-20 days.

Link to Purchase Tauri-Gum™ Hanukkah Special Gift Pack:

Link: https://taurigum.com/products/hannukah-gift-special

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives. The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

555 Madison Avenue, 5th Floor

New York, NY 10022

Chief Executive Officer

Mr. Seth M. Shaw

Email: sshaw@tauriga.com

cell # (917) 796 9926

Instagram: @taurigum

Twitter: @SethMShaw

Corp. Website: www.tauriga.com

E-Commerce Website: www.taurigum.com

Attachment